Clinical Trial Update: Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a kappa opioid receptor antagonist for treating alcohol use disorder with comorbid PTSD; study terminated with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Post-traumatic Stress Disorder

Snippet

Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | Conditions: Post Traumatic Stress Disorder, Alcohol Abuse | Phase 2 | Status: TERMINATED | Results posted: 2023-06-07